Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2004Clinical ChemistryOpen Access

Time Course of B-Type Natriuretic Peptide (BNP) and N-Terminal ProBNP Changes in Patients with Decompensated Heart Failure

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does levosimendan infusion lead to rapid changes in BNP and NT-proBNP levels corresponding to hemodynamic improvements in patients with decompensated heart failure?

Population

11 consecutive patients with acute decompensation of chronic heart failure requiring hemodynamic monitoring…

Design

Cohort

Follow-up

24 hours

Authors

AGAlfons GegenhuberInnsbruck Medical UniversityTMThomas MuellerGeneral CardiologyFFF FirlingerConvent Hospital of the Brothers of Saint John of God

Discussion

Loading...

Member takes

Overview

Early BNP decline may mark rapid levosimendan response in decompensated HF; leaves open whether it should guide therapy over NT-proBNP.

Structured PICO

Does levosimendan infusion lead to rapid changes in BNP and NT-proBNP levels corresponding to hemodynamic improvements in patients with decompensated heart failure?

P
Population
11 consecutive patients with acute decompensation of chronic heart failure requiring hemodynamic monitoring and intravenous treatment, LVEF ≤30%, PCWP ≥15 mmHg, and CI ≤2.5 L/min/m2. Mean age 62 years, 10 males and 1 female. NYHA class III (n=3) to IV (n=8).
I
Intervention
Levosimendan initiated with an intravenous bolus of 24 μg/kg over 10 min, followed by continuous infusion of 0.1 μg/kg/min for 50 min, then increased to 0.2 μg/kg/min for the next 23 hours.
O
Outcome
Time-dependent changes in hemodynamics (PCWP, CI) and BNP and NT-proBNP values at 10 min, 60 min, 120 min, 6 h, and 24 h.surrogate

BNP responds more rapidly than NT-proBNP to hemodynamic improvements during levosimendan therapy in decompensated heart failure, reflecting its shorter biological half-life.

Limitations

  • Small number of patients
  • Limited statistical power
  • Preponderance of males
  • Unable to make conclusions concerning the optimum time interval for monitoring patients on a routine clinical basis

Cite This Study

Gegenhuber et al. (2004) studied this question.

synapsesocial.com/papers/6a760c219aebbbed36613c8chttps://doi.org/10.1373/clinchem.2003.028712
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload2000 · 209 citations
  2. 2Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure2000 · 482 citations
  3. 3Sustained Hemodynamic Effects of Intravenous Levosimendan2003 · 259 citations